Abiraterone Ethyl Ether is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
SKU | RCLST525801 |
---|---|
Molecular Formula | C26H35NO |
Catalog Number | RCLST525801 |
Chemical Name | Abiraterone Ethyl Ether |
Molecular Weight | 377.56 |
Solubility | Chloroform (Slightly), Ethyl Acetate (Slightly) |
Stability | No Data Available |
Appearance | White to Off-White Solid |
Storage Condition | Refrigerator |